Bank of New York Mellon’s Altimmune ALT Stock Holding History

Bank of New York Mellon’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.1M	Buy	689,713 +276,210	+67%	+$825K	﹤0.01%	2923
2026 Q1	$1.27M	Buy	413,503 +59,302	+17%	+$252K	﹤0.01%	3064
2025 Q4	$1.28M	Buy	354,201 +12,216	+4%	+$53.3K	﹤0.01%	3094
2025 Q3	$1.29M	Buy	341,985 +9,969	+3%	+$38.5K	﹤0.01%	3058
2025 Q2	$1.28M	Buy	332,016 +143,016	+76%	+$774K	﹤0.01%	2983
2025 Q1	$945K	Buy	189,000 +2,162	+1%	+$13.7K	﹤0.01%	3101
2024 Q4	$1.35M	Sell	186,838 -1,777	-0.9%	-$13.6K	﹤0.01%	2962
2024 Q3	$1.16M	Sell	188,615 -55,193	-23%	-$374K	﹤0.01%	3058
2024 Q2	$1.62M	Buy	243,808 +54,154	+29%	+$400K	﹤0.01%	2913
2024 Q1	$1.93M	Sell	189,654 -1,934	-1%	-$19.7K	﹤0.01%	2777
2023 Q4	$2.16M	Buy	191,588 +12,681	+7%	+$52.9K	﹤0.01%	2793
2023 Q3	$465K	Sell	178,907 -15,216	-8%	-$43.7K	﹤0.01%	3583
2023 Q2	$685K	Buy	194,123 +135,169	+229%	+$607K	﹤0.01%	3427
2023 Q1	$249K	Buy	58,954 +5,662	+11%	+$67.3K	﹤0.01%	3825
2022 Q4	$877K	Sell	53,292 -19,804	-27%	-$222K	﹤0.01%	3256
2022 Q3	$934K	Buy	73,096 +24,051	+49%	+$355K	﹤0.01%	3239
2022 Q2	$574K	Sell	49,045 -148,202	-75%	-$914K	﹤0.01%	3508
2022 Q1	$1.2M	Sell	197,247 -2,949	-1%	-$21.7K	﹤0.01%	3201
2021 Q4	$1.83M	Buy	200,196 +39,013	+24%	+$415K	﹤0.01%	3042
2021 Q3	$1.82M	Buy	161,183 +26,332	+20%	+$320K	﹤0.01%	3038
2021 Q2	$1.33M	Buy	134,851 +79,494	+144%	+$1.09M	﹤0.01%	3243
2021 Q1	$782K	Sell	55,357 -4,638	-8%	-$75K	﹤0.01%	3472
2020 Q4	$677K	Buy	59,995 +5,448	+10%	+$64.2K	﹤0.01%	3467
2020 Q3	$720K	Buy	54,547 +12,137	+29%	+$243K	﹤0.01%	3307
2020 Q2	$454K	Hold	42,410	–	–	﹤0.01%	3530
2020 Q1	$136K	Sell	42,410 -33,842	-44%	-$77.8K	﹤0.01%	3823
2019 Q4	$144K	Hold	76,252	–	–	﹤0.01%	3973
2019 Q3	$149K	Buy	76,252 +43,013	+129%	+$95.3K	﹤0.01%	3967
2019 Q2	$79K	Buy	+33,239	New	+$88.9K	﹤0.01%	4067
2018 Q3	–	Sell	-2,211	Closed	-$30K	–	4241
2018 Q2	$30K	Buy	+2,211	New	+$43.5K	﹤0.01%	4144
2018 Q1	–	Sell	-2,297	Closed	-$137K	–	4312
2017 Q4	$137K	Buy	+2,297	New	+$147K	﹤0.01%	4023
2017 Q2	–	Sell	-610	Closed	-$149K	–	4293
2017 Q1	$149K	Hold	610	–	–	﹤0.01%	3946
2016 Q4	$594K	Buy	610 +62	+11%	+$55.5K	﹤0.01%	3510
2016 Q3	$477K	Sell	548 -29	-5%	-$22.7K	﹤0.01%	3565
2016 Q2	$423K	Buy	577 +392	+212%	+$268K	﹤0.01%	3608
2016 Q1	$105K	Buy	185 +11	+6%	+$5.63K	﹤0.01%	3951
2015 Q4	$99K	Hold	174	–	–	﹤0.01%	4067
2015 Q3	$69K	Hold	174	–	–	﹤0.01%	4198
2015 Q2	$94K	Buy	174 +33	+23%	+$16.7K	﹤0.01%	4057
2015 Q1	$69K	Hold	141	–	–	﹤0.01%	4109
2014 Q4	$76K	Hold	141	–	–	﹤0.01%	4103
2014 Q3	$75K	Hold	141	–	–	﹤0.01%	4114
2014 Q2	$60K	Buy	141 +1	+0.7%	+$452	﹤0.01%	4060
2014 Q1	$77K	Hold	140	–	–	﹤0.01%	4029
2013 Q4	$78K	Sell	140 -4	-3%	-$2.39K	﹤0.01%	4062
2013 Q3	$91K	Buy	144 +4	+3%	+$2.29K	﹤0.01%	3973
2013 Q2	$67K	Buy	+140	New	+$69.4K	﹤0.01%	4000

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BWCS

Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BWM

Brown Wealth Management Naperville, Illinois $447M AUM 16.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Bank of New York Mellon's ALT Position: Q2 2026 in Review

Bank of New York Mellon increased its Altimmune (ALT) stake by 67% in Q2 2026, buying an estimated $825K and bringing the position to 689,713 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2923.

Bank of New York Mellon first reported a position in ALT in Q2 2013 and has held it in 47 quarters since. The position peaked at $2.16M in Q4 2023. 83 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Bank of New York Mellon held 689,713 shares of Altimmune worth $2.1M as of Q2 2026.
Bank of New York Mellon bought 276,210 Altimmune shares in Q2 2026, an estimated $825K.
Altimmune made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2923 holding.
Bank of New York Mellon first reported a position in Altimmune in Q2 2013 and has held it in 47 quarters since.
Bank of New York Mellon's Altimmune position peaked at $2.16M in Q4 2023.
83 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.